Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
Open Access
- 2 August 2022
- journal article
- research article
- Published by Elsevier in Neurotherapeutics
- Vol. 19 (5) , 1546-1565
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education (BK21 FOUR)
- Cooperative Research Program for Agriculture Science and Technology Development (PJ01640202)
- Novemetahealth
This publication has 64 references indexed in Scilit:
- Aberrant Protein S-Nitrosylation in Neurodegenerative DiseasesNeuron, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseasesJournal of Advanced Pharmaceutical Technology & Research, 2011
- Angiotensin II AT1 Receptor Blockade Ameliorates Brain InflammationNeuropsychopharmacology, 2010
- Peroxisome Proliferator-Activated Receptor δ Regulates Inflammation via NF-κB Signaling in Polymicrobial SepsisThe American Journal of Pathology, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseJournal of Neuroinflammation, 2008
- PPAR Regulation of Inflammatory Signaling in CNS DiseasesPPAR Research, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005